Juha Kononen

18.7k citations

83 papers · 13.5k indexed · 4 hit papers · h-index 43

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways

Papers in

Behavioral Neuroscience 7
- Stress Responses and Cortisol 7
Oncology 31
- HER2/EGFR in Cancer Research 13
- Cancer-related Molecular Pathways 8

Co-authors: Guido Sauter Olli Kallioniemi Lukas Bubendorf Peter Schraml Michael J. Mihatsch J. Torhorst Maarit Bärlund Stephen B. Leighton
Journals: American Journal Of Pathology (5 papers)JNCI Journal of the National Cancer Institute (3 papers)The Journal of Pathology (3 papers)Endocrinology (3 papers)Nature Genetics (3 papers)
Partner nations: Finland United States Switzerland

In The Last Decade

Juha Kononen

83 papers receiving 13.1k citations

Hit Papers

align trajectories log scale

POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. 2003 · 502 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 PubMed
1998 Nature Medicine
1997 Science
1997 PubMed

Peers

Countries citing papers authored by Juha Kononen

Since Specialization

Citations

This map shows the geographic impact of Juha Kononen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juha Kononen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juha Kononen more than expected).

Fields of papers citing papers by Juha Kononen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juha Kononen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juha Kononen. The network helps show where Juha Kononen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Juha Kononen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Juha Kononen Line = papers co-authored together Juha Kononen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020 Cancer Treatment and Research Communications ·Andrzej Skraba, JISSREL ACABO, Pekka Mali, Anu Anttonen, Kaisa Lehtiö, Maria Tengström, Nadiezka Milan Cristo, Shubin Cheng, Liisa Sailas, Rikke Prejh Brochmann, Vanda Kašauskienė, Juha Kononen, Q. Shen, Antti Jekunen	2025	1
2	607P Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy +/- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy) Annals of Oncology ·Pia Österlund, Emerik Österlund, Päivi Halonen, Mike Voll, Arno Nordin, Muscha Jm, Tapio Salminen, Ana Rodríguez Macías, Serge Aho, Annika Ålgars, Raija Ristamäki, Eetu Heervä, Raija Kallio, Annamarja Lamminmäki, K. Kovári, Timo Muhonen, Teijo Kuopio, Juha Kononen, Bengt Glimelius, Helena Isoniemi	2023	1
3	Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma Frontiers in Oncology ·Daniel Martínez Molinero, Rami Mäkelä, Antti Arjonen, Ville Härmä, Laura B. Lewandowski, M Sreekutty, 朱文焕, Ismo T. Jantunen, Teijo Kuopio, Juha Kononen, Juha Rantala	2021	4
4	Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case Anticancer Research ·Ana Rodríguez Macías, Laura Lahtinen, N. Penzel, Teijo Kuopio, Ivana Kholová, Rami Mäkelä, Juha Rantala, Pirkko‐Liisa Kellokumpu‐Lehtinen, Juha Kononen	2019	7
5	The correlation between cellular size and protein expression levels — Normalization for global protein profiling Journal of Proteomics ·Emma Lundberg, Marcus Gry, Per Oksvold, Juha Kononen, Helene Andersson Svahn, Fredrik Pontén, Mathias Uhlén, Anna Asplund	2008	19
6	A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer The American Journal of Human Genetics ·Pia Vahteristo, Jiřina Bártková, Hannaleena Eerola, Kirsi Syrjäkoski, Ran Pang, Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina Aittomäki, Päivi Heikkilä, Kaija Holli, Carl Blomqvist, Jiří Bártek, Olli Kallioniemi, Heli Nevanlinna	2002	346
7	Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome American Journal Of Pathology ·Matt van de Rijn, Charles M. Perou, Rob Tibshirani, 久美子奥野, Olli Kallioniemi, Juha Kononen, J. Torhorst, Guido Sauter, Markus Zuber, Ossi R. Köchli, Frank Mross, Holger Dieterich, Lianghze Chen, D. T. Ross, David Botstein, Pat Brown	2002	465
8	CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas American Journal Of Pathology ·Peter Schraml, Kirsten Struckmann, M. Annapoorna, Wenting Fu, Thomas Gasser, Kim Wilber, Juha Kononen, Guido Sauter, Michael J. Mihatsch, Holger Moch	2001	41
9	Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints American Journal Of Pathology ·J. Torhorst, Christoph Bucher, Juha Kononen, Philippe Haas, Markus Zuber, Ossi R. Köchli, Frank Mross, Holger Dieterich, Holger Moch, Michael J. Mihatsch, Olli Kallioniemi, Guido Sauter	2001	438
10	Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer JNCI Journal of the National Cancer Institute ·Ronald Simon, Antonio Nocito, Huaitao Yu, Christoph Bucher, J Torhorst, Peter Schraml, Lukas Bubendorf, M Mihatsch, Holger Moch, Kim Wilber, Andreas Schötzau, Juha Kononen, Guido Sauter	2001	238
11	Tissue Microarrays: What Will They Bring to Molecular and Anatomic Pathology? Advances in Anatomic Pathology ·Holger Moch, Juha Kononen, Olli Kallioniemi, Guido Sauter	2001	118
12	Novel findings in gene expression detected in human osteosarcoma by cDNA microarray Cancer Genetics and Cytogenetics ·Maija Wolf, Wael El‐Rifai, Maija Tarkkanen, Juha Kononen, Massimo Serra, Erik Fink Eriksen, Inkeri Elomaa, Anne Kallioniemi, Olli Kallioniemi, Sakari Knuutila	2000	52
13	Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray Analysis JNCI Journal of the National Cancer Institute ·Maarit Bärlund, Farahnaz Forozan, Juha Kononen, Lukas Bubendorf, Yaning Chen, Michael Bittner, J. Torhorst, Peter Haas, Christoph Bucher, G Sauter, Olli Kallioniemi, Anne Kallioniemi	2000	234
14	Chromosome imbalances in familial gliomas detected by comparative genomic hybridization Genes Chromosomes and Cancer ·Iyongo Godfrey, Satu‐Leena Sallinen, Ritva Karhu, Helena E. Miettinen, P Sallinen, Juha Kononen, Pékka Laippala, K. O. J. Simola, L.-P. Wang, Hannu Haapasalo	2000	22
15	Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. PubMed ·Sigurður Ingvarsson, Bjarni A. Agnarsson, Deng TB, Juha Kononen, Olli Kallioniemi, R B Barkardottir, Albert J. Kovatich, Roland Schwarting, Walter W. Hauck, K Huebner, Peter A. McCue	1999	40
16	CDKN2/p16 Predicts Survival in Oligodendrogliomas: Comparison with Astrocytomas Journal of Neuro-Oncology ·Helena E. Miettinen, Juha Kononen, P Sallinen, Hannu Alho, Pauli Helén, Heikki Helin, Hannu Kalimo, Leo Paljärvi, J Isola, Hannu Haapasalo	1999	42
17	Genome screening by comparative genomic hybridization Trends in Genetics ·Farahnaz Forozan, Ritva Karhu, Juha Kononen, Anne Kallioniemi, Olli Kallioniemi	1997	220
18	Effects of ageing on the expression of neurotrophins and their receptors in the rat pituitary gland Neuroreport ·Juha Kononen, Tomas Hökfelt, Markku Pelto‐Huikko	1995	22
19	Glucocorticoid receptor colocalization with pituitary hormones in the rat pituitary gland Molecular and Cellular Endocrinology ·Juha Kononen, Jari Honkaniemi, Jan-Ακε Gustafsson, Markku Pelto‐Huikko	1993	48
20	Circadian rhythm in c-fos-like immunoreactivity in the rat brain Neuroscience Letters ·Juha Kononen, Jari Koıstınaho, Hannu Alho	1990	87

About Juha Kononen

Juha Kononen is a scholar working on Behavioral Neuroscience, Oncology, Cancer Research, Genetics and Reproductive Medicine, having authored 83 papers that have together received 13.5k indexed citations. Recurring topics across this work include Gene expression and cancer classification (14 papers), HER2/EGFR in Cancer Research (13 papers), Genomic variations and chromosomal abnormalities (11 papers), Molecular Biology Techniques and Applications (10 papers), Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Stress Responses and Cortisol (7 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (4.8k citations), Molecular Biology (8.0k citations), Genetics (2.8k citations) and Pulmonary and Respiratory Medicine (2.6k citations). Juha Kononen has collaborated with scholars based in Finland, United States and Switzerland. Frequent co-authors include Guido Sauter, Olli Kallioniemi, Lukas Bubendorf, Peter Schraml, Michael J. Mihatsch, J. Torhorst, Maarit Bärlund, Stephen B. Leighton, Jorma Isola and Holger Moch. Their work appears in journals such as American Journal Of Pathology, JNCI Journal of the National Cancer Institute, The Journal of Pathology, Endocrinology and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact